NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
September 4, 2024 — Clene Inc. and its subsidiary, Clene Nanomedicine Inc., to present at the H.C. Wainwright 26th Annual Global Investment Conference and host 1x1 investor meetings. The company is focused on improving mitochondrial health to treat neurodegenerative diseases, including ALS and MS.
September 4, 2024 — Cingulate introduces Precision Timed Release™ (PTR™) technology, revolutionizing drug delivery and addressing underserved medical needs. Learn more about Cingulate's breakthrough on Benzinga's All Access.
September 4, 2024 — American Heart Association and NFL collaborate to promote student physical activity through the NFL PLAY 60 program, emphasizing the importance of physical health and well-being for children. The initiative aims to establish healthy habits at a young age, contributing to longer, healthier lives for students.
September 4, 2024 — Hyro announces the return of Digital Front Door Day, a premier virtual summit dedicated to revolutionizing healthcare access and delivery. The event will feature renowned speakers such as Amir Dan Rubin, former CEO of One Medical, and will include 42 speakers from 32 leading healthcare organizations sharing their insights and case studies.
September 3, 2024 — American Heart Association, Kansas City Chiefs, and NFL launch health and safety programs at Three Trails Elementary School, promoting physical activity, CPR education, and heart health for children.
September 3, 2024 — The PAD Collaborative releases an interactive heat map to highlight the risk of non-traumatic lower limb amputations, a severe complication of peripheral artery disease (PAD), offering specific data for each state and aiming to prevent PAD, reduce complications, and improve quality of life.
September 3, 2024 — PathAI collaborates with GoldPath to elevate digital pathology capabilities with AISight Image Management System. The integration of digital pathology is becoming a critical differentiator for independent laboratories, aiming to reduce turnaround times for referring physicians and deliver cutting-edge pathology services.
September 3, 2024 — Clene (NASDAQ: CLNN) is revolutionizing treatment for neurodegenerative diseases with its lead agent, CNM-Au8, targeting the NAD+ pathway to improve cellular energy production and utilization. Extensive clinical trials have shown CNM-Au8's strong safety profile, positioning Clene as a leader in addressing ALS and MS.
September 3, 2024 — GeoVax Labs CEO to present at investor events, highlighting the latest developments in biotechnology and clinical trials for COVID-19 vaccine and cancer therapy.
September 3, 2024 — Mainz BioMed CFO discusses the company's commitment to saving lives through early disease detection and prevention, including genetic and genomic tests. Learn more about their progress and promising data from recent trials.
September 3, 2024 — Mainz Biomed's breakthrough colorectal cancer test offers hope for improved early detection and survival rates, potentially impacting the multi-billion dollar U.S. market for colorectal screening and expanding into other gastrointestinal cancers.
September 3, 2024 — REMsleep Holdings, Inc. receives new patent allowance and prepares for product launches, signaling growth and innovation in sleep apnea treatment.
September 3, 2024 — The 2024 Live Your Lyrics event brings together music, unity, and a profound mission to break the silence on suicide, foster open conversations, and support those in need. Join the event to unite for a critical cause and embrace hope for change.
September 2, 2024 — Discover the strategic appeal of the Health Care Select Sector SPDR Fund (XLV) in providing diversified exposure to the U.S. healthcare sector. Learn about the significance of healthcare in the economy and the investment opportunities it presents.
August 31, 2024 — Harper Ellsworth Advertising and Texas Radiotherapy recognized as finalists for the 2024 MM+M Awards, showcasing outstanding work in healthcare marketing and raising awareness about prostate cancer.
August 29, 2024 — Clene's CNM-Au8 trials for ALS and MS treatment show promise for improving patient outcomes. The innovative approach could have a significant impact on the therapeutic market.
August 29, 2024 — Syntekabio introduces 'Develop Now, Pay Later' offer to minimize risk, save time and costs, and increase the success rate of companies developing novel therapies.
August 29, 2024 — Monogram Orthopedics prepares to launch its next-gen surgical robot, positioning itself to capitalize on the growing orthopedic surgery robotic market. Surgeons discuss the impact of the company's technology on patient care and outcomes.
August 29, 2024 — Nuvectis Pharma has achieved a significant milestone with the FDA granting Orphan Drug Designation for NXP800, a potential game-changer in oncology. This news highlights the urgent need for innovative treatments in rare cancers, offering hope for patients and strategic benefits for the company.
August 29, 2024 — Aclarion expands CLUE Trial to New Jersey with Dr. Justin Kubeck joining the network of surgeons. The trial aims to identify how often Nociscan's AI data changes the initial treatment plan for patients with chronic low back pain.